trial

Intensive Transcranial Magnetic Stimulation for Negative Symptoms in Schizophrenia

NCTId NCT02127879
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 40 (estimated)
Sponsored by Brno University Hospital
Primary completion 2016-10
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
40 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2014-05
Primary completion
2016-10
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
Transcranial Magnetic Stimulation

Sponsors

Brno University HospitalLead Sponsor
Masaryk UniversityCollaborator

Investigators

2
Tomáš Svěrák, Mgr.Principal Investigator
Radovan Přikryl, Prof.Study Director

Sites

1 total
Brno, Czechia

Facts & assertions

4 sourced
Enrollment
40
Phase
NA
Primary Completion Date
2016-10
Status
UNKNOWN
relationships
The graph out of here
drug
Transcranial Magnetic Stimulation
drug
lead_sponsor
Brno University Hospital
company
collaborator
Masaryk University
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Tomáš Svěrák, Mgr.
person
Radovan Přikryl, Prof.
person